Significant Ownership of Ho Chi Sing
- Signature - Title
- /s/ Ho Chi Sing - Ho Chi Sing
- Location
- Hong Kong
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Ho Chi Sing.
Follow Filing Activity
Follow Ho Chi Sing and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Ho Chi Sing
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares, par value US$0.0001 per share | 4.8% | $754,405 | 992,638 | 0% | Zhou Quan | 30 Sep 2025 | |
| PONY | Pony AI Inc. | Class A ordinary shares, par value US$0.0005 per share | 4.3% | $343,510,641 | -$66,897,472 | 15,273,928 | -16% | IDG China Venture Capital Fund IV L.P. | 30 Sep 2025 |
Schedules 13D/G Reported by Ho Chi Sing:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.